ABL Bio Inc. (KOSDAQ: 298380)

ABL Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-49,041	-2,647	3,209	-43,558
Depreciation & Amortization	2,442	2,590	2,325	2,158
Loss (Gain) From Sale of Assets	0.34	2.64	-48	5.83
Loss (Gain) From Sale of Investments	-855.63	-1,132	592.13	-6,666
Stock-Based Compensation	3,657	6,001	4,382	7,521
Provision & Write-off of Bad Debts	-	-	-	-682.58
Other Operating Activities	2,543	-203.88	1,352	-15.18
Change in Unearned Revenue	-31,859	-31,859	63,562	-3,160
Change in Other Net Operating Assets	1,924	-1,113	-3,242	3,792
Operating Cash Flow	-71,189	-28,362	72,132	-40,605
Capital Expenditures	-10,210	-5,740	-2,055	-1,244
Sale of Property, Plant & Equipment	0.45	7.46	74.51	12
Cash Acquisitions	-	-	-21,256	-
Sale (Purchase) of Intangibles	-50.75	-104.41	-330.07	-21.4
Investment in Securities	64,096	35,941	-46,234	21,458
Other Investing Activities	33.64	-20.49	-196.46	17.62
Investing Cash Flow	53,669	29,884	-71,250	20,221
Long-Term Debt Issued	-	44,831	-	-
Long-Term Debt Repaid	-	-43,130	-1,091	-959.45
Net Debt Issued (Repaid)	1,718	1,701	-1,091	-959.45
Issuance of Common Stock	1,097	1,717	5,753	1,256
Other Financing Activities	-179.71	-1,981	-11.67	-12.36
Financing Cash Flow	142,635	1,437	4,649	284.13
Foreign Exchange Rate Adjustments	-2,192	-29.86	-1,984	1,030
Net Cash Flow	122,922	2,929	3,547	-19,070
Free Cash Flow	-81,400	-34,102	70,076	-41,850
Free Cash Flow Margin	-251.85%	-52.03%	104.12%	-784.87%
Free Cash Flow Per Share	-1697.74	-712.77	1473.24	-890.99
Cash Interest Paid	2,057	2,521	1,205	-
Cash Income Tax Paid	-	1,621	-2.6	-75.7
Levered Free Cash Flow	-66,001	-37,710	63,171	-
Unlevered Free Cash Flow	-65,870	-36,365	64,000	-
Change in Net Working Capital	27,235	32,186	-62,291	-

Source: S&P Capital IQ. Standard template. Financial Sources.